Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.

In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability ...

The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...

Stop falling for misleading headlines. Understand the difference between correlation and causation, and learn how researchers ...

Savvy developers are realizing the advantages of writing explicit, consistent, well-documented code that agents easily ...

Dyne Therapeutics (NASDAQ:DYN) executives outlined a slate of 2026 operational and regulatory milestones during a discussion ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, raising hopes for a disease-modifying treatment.

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

New federal lawsuit claims the loot box function by Valve acts like gambling while global regulators debate legality of ...

Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...